HC Wainwright backs Achieve Life Sciences with a Buy rating as cytisinicline nears potential 2026 FDA approval, targeting a large smoking cessation market.
Latest Ratings for ACHV
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 2021 | Alliance Global Partners | Initiates Coverage On | Buy | |
| Jun 2021 | Oppenheimer | Initiates Coverage On | Outperform | |
| Sep 2020 | Lake Street | Initiates Coverage On | Buy |
